Cargando…
Idebenone increases chance of stabilization/recovery of visual acuity in OPA1‐dominant optic atrophy
We previously documented that idebenone treatment in OPA1‐Dominant Optic Atrophy (OPA1‐DOA) led to some degrees of visual improvement in seven patients. We here present the results of a cohort study, which investigated the effect of off‐label idebenone administration in a larger OPA1‐DOA group compa...
Autores principales: | Romagnoli, Martina, La Morgia, Chiara, Carbonelli, Michele, Di Vito, Lidia, Amore, Giulia, Zenesini, Corrado, Cascavilla, Maria Lucia, Barboni, Piero, Carelli, Valerio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7187718/ https://www.ncbi.nlm.nih.gov/pubmed/32243103 http://dx.doi.org/10.1002/acn3.51026 |
Ejemplares similares
-
Therapeutic Options in Hereditary Optic Neuropathies
por: Amore, Giulia, et al.
Publicado: (2020) -
Hearing Dysfunction in a Large Family Affected by Dominant Optic Atrophy (OPA8-Related DOA): A Human Model of Hidden Auditory Neuropathy
por: Santarelli, Rosamaria, et al.
Publicado: (2019) -
First TMEM126A missense mutation in an Italian proband with optic atrophy and deafness
por: La Morgia, Chiara, et al.
Publicado: (2019) -
Dominant Optic Atrophy (DOA): Modeling the Kaleidoscopic Roles of OPA1 in Mitochondrial Homeostasis
por: Del Dotto, Valentina, et al.
Publicado: (2021) -
Medical Management of Hereditary Optic Neuropathies
por: La Morgia, Chiara, et al.
Publicado: (2014)